Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience.

Date publication

janvier 2013

Journal

Chemotherapy

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GHIRINGHELLI François , Dr LADOIRE Sylvain , Dr VINCENT Julie

Tous les auteurs :
Ghiringhelli F, Lorgis V, Vincent J, Ladoire S, Guiu B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/24821200

Résumé

The aim of this study was to evaluate the efficacy and tolerability of hepatic arterial infusion (HAI) of gemcitabine plus oxaliplatin as second-line treatment for unresectable locally advanced intrahepatic cholangiocarcinoma.

Mots clés

Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, administration & dosage, Bile Duct Neoplasms, drug therapy, Bile Ducts, Intrahepatic, pathology, Cholangiocarcinoma, drug therapy, Deoxycytidine, administration & dosage, Disease Progression, Female, Hepatic Artery, Humans, Infusions, Intra-Arterial, Male, Middle Aged, Organoplatinum Compounds, administration & dosage, Retrospective Studies, Survival Rate, Treatment Outcome

Référence

Chemotherapy. 2013 ;59(5):354-60